Skip to main content

and
  1. Article

    Open Access

    Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5

    The use of shRNAs to downregulate the expression of specific genes is now relatively routine in experimentation but still hypothetical for clinical application. A potential therapeutic approach for HIV-1 disea...

    Saki Shimizu, Masakazu Kamata, Panyamol Kittipongdaja in Genetic Vaccines and Therapy (2009)